Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

This study has been completed.

Study NCT00074867 Information provided by Pfizer

First Received: December 22, 2003 Last Updated: November 6, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2004
Estimated Primary Completion Date:	No date given